Study guide
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis
Key Takeaways Explain This Topic AI
Bacterial vaginosis is an ecological dysbiosis from loss of hydrogen-peroxide-producing Lactobacillus, not infection by a single pathogen.
Amsel criteria require 3 of 4: thin homogeneous discharge, vaginal pH above 4.5, a positive whiff-amine test, and clue cells on more than 20 percent of squamous cells.
The Nugent score on Gram stain is the laboratory gold standard for bacterial vaginosis.
Vaginal pH is normal in candidiasis, typically 4.0 to 4.5, but elevated above 4.5 in both bacterial vaginosis and trichomoniasis.
Trichomoniasis is caused by a flagellated protozoan and is sexually transmitted, which makes partner treatment necessary, unlike bacterial vaginosis.
Last updated: September 2026
Vaginal discharge, vulvar pruritus, and pelvic pain are among the most common presenting complaints in ambulatory women's health. The normal vaginal ecosystem is a finely balanced microenvironment dominated by hydrogen peroxide-producing Lactobacillus species ( L. crispatus , L. jensenii ), which ferment glycogen into lactic acid to maintain an acidic protective vaginal pH of 3.8 to 4.5 . Disruptions in this protective barrier permit polymicrobial dysbiosis, fungal proliferation, or colonization by virulent sexually transmitted pathogens. For the certified nurse-midwife, precise clinical microscopy, rapid diagnostic triaging, strict adherence to CDC treatment guidelines, and timely intervention for pelvic inflammatory disease are essential to prevent long-term sequelae such as tubal factor infertility, ectopic pregnancy, and preterm birth.
Differential Diagnosis of Common Vaginitis
Vaginitis is clinically classified into three predominant conditions: Bacterial Vaginosis (BV) , Vulvovaginal Candidiasis (VVC) , and Trichomoniasis . Diagnostic accuracy relies on the synthesis of clinical presentation, nitrazine pH testing, the 10% potassium hydroxide (KOH) amine whiff test, and direct point-of-care microscopy.
Diagnostic Parameter Bacterial Vaginosis (BV) Vulvovaginal Candidiasis (VVC) Trichomoniasis
Etiologic Agent Polymicrobial dysbiosis: Loss of protective Lactobacillus ; overgrowth of Gardnerella vaginalis , Atopobium vaginae , Prevotella , Mobiluncus , and anaerobes Candida albicans (85%–90%); Candida glabrata (10%–15%); opportunistic fungal overgrowth Trichomonas vaginalis : flagellated, anaerobic parasitic protozoan; sexually transmitted
Typical Discharge Thin, homogeneous, off-white or gray; smoothly coats vaginal walls; non-adherent Thick, white, curd-like, flocculent "cottage cheese" ; adheres tenaciously to vaginal mucosa Copious, thin-to-purulent, frothy yellow-green ; foul or musty odor
Primary Symptoms Pronounced "fishy" odor (worse after intercourse or menses); mild vulvar discomfort; absent inflammation Intense vulvar pruritus , burning, excoriations, dyspareunia, external "splash" dysuria Marked vulvar pruritus, burning, severe dyspareunia, postcoital spotting, dysuria
Vaginal pH Elevated (>4.5) , typically 5.0 to 5.5 Normal acidic (4.0 to 4.5) Elevated (>4.5) , typically 5.0 to 7.0
10% KOH Whiff Test Positive (Sharp, pungent fishy amine odor released upon adding KOH) Negative (No amine odor) Frequently Positive or variable
Saline Wet Mount Clue cells present (>20%) ; stippled borders obscured by coccobacilli; absent WBCs Intact squamous cells; abundant white blood cells (WBCs); blastoconidia and pseudohyphae Motile, flagellated trichomonads with jerky, twitching motility; abundant WBCs
10% KOH Wet Mount Dissolves epithelial cells; clue cells cleared Budding yeast (blastospores) & branching pseudohyphae visualized clearly Protozoa lyse; non-diagnostic
Physical Exam Normal vulva and vaginal mucosa; lack of erythema or edema Intense erythema and edema of vulva/labia; satellite pustules; mucosal fissures Severe vaginal erythema; Colpitis macularis ("strawberry cervix") with punctate hemorrhages
CDC First-Line Treatment Metronidazole 500 mg PO BID x 7 days OR Metronidazole gel 0.75% 5 g PV daily x 5 days OR Clindamycin 2% cream 5 g PV qhs x 7 days Fluconazole 150 mg PO single dose (Uncomplicated non-pregnant) OR Topical azoles (Clotrimazole 1%–2% cream PV x 7 days) Metronidazole 500 mg PO BID x 7 days (Preferred for women) OR Tinidazole 2 g PO single dose
Partner Management Partner treatment NOT recommended (does not prevent recurrence) Partner treatment NOT recommended (not an STI) MANDATORY simultaneous treatment of all sexual partners ; Expedited Partner Therapy (EPT)
Obstetric Risks Strongly linked to Preterm Labor (PTL), PPROM, chorioamnionitis, and postpartum endometritis Discomfort; oral fluconazole contraindicated in pregnancy (use 7-day topical azoles only) Premature rupture of membranes, preterm birth, low birth weight infant
Bacterial Vaginosis: Pathogenesis & Diagnostic Criteria
Bacterial Vaginosis (BV) is the most prevalent cause of abnormal vaginal discharge in reproductive-age individuals. It is not an infection of a single pathogen, but rather an ecological dysbiosis characterized by the catastrophic collapse of hydrogen peroxide-producing Lactobacillus species. In their absence, facultative and obligate anaerobic bacteria proliferate up to 1,000-fold. These anaerobes produce decarboxylase enzymes that convert amino acids into volatile amines (putrescine, cadaverine, trimethylamine), which volatilize at high pH and generate the characteristic fishy malodor.
Amsel Clinical Criteria
Diagnosis requires the presence of at least 3 of the following 4 criteria :
Thin, homogeneous, white-to-gray discharge smoothly coating the vaginal walls.
Vaginal pH >4.5 (measured using narrow-range nitrazine paper touched to lateral vaginal wall).
Positive Whiff-Amine Test: Release of a distinct fishy amine odor immediately following the addition of one drop of 10% potassium hydroxide (KOH) to vaginal secretions.
Clue Cells on Saline Wet Mount: Greater than 20% of squamous vaginal epithelial cells must be clue cells (squamous cells whose borders are completely obscured and stippled by masses of adherent coccobacilli, giving a "ground-glass" appearance, with loss of sharp cellular margins).
Nugent Score (Laboratory Gold Standard)
A standardized Gram stain scoring system (0 to 10) evaluating the proportion of large Gram-positive rods ( Lactobacillus morphotypes), small Gram-variable rods ( Gardnerella and Bacteroides morphotypes), and curved Gram-variable rods ( Mobiluncus ). A score of 7 to 10 is definitively diagnostic of BV (0–3 is normal; 4–6 is intermediate).
CDC Recommended Treatment & Clinical Nuances
First-Line Regimens:
Metronidazole 500 mg PO BID for 7 days (highest efficacy for eradicating systemic and vaginal reservoirs).
Metronidazole 0.75% vaginal gel , one full applicator (5 g) intravaginally once daily at bedtime for 5 days.
Clindamycin 2% vaginal cream , one full applicator (5 g) intravaginally at bedtime for 7 days.
Patient Counseling: Advise patients taking oral metronidazole to avoid alcohol consumption during therapy and for at least 24 hours afterward to prevent disulfiram-like ethanol reactions (nausea, vomiting, abdominal cramping, flushing, tachycardia). Clindamycin cream is oil-based and can weaken latex condoms and diaphragms for up to 72 hours post-treatment.
Pregnancy Considerations: Symptomatic pregnant individuals should be treated with either oral Metronidazole 500 mg BID for 7 days or oral Clindamycin 300 mg BID for 7 days. Treatment relieves symptoms and eliminates bacterial reservoirs associated with preterm birth, chorioamnionitis, and postpartum endometritis.